U.S. Pharma Stock News

Why Blackbaud stock is drawing interest now Blackbaud (BLKB) has been under pressure, with the share price showing negative returns over the past month and past 3 months. This is prompting investors to reassess what they are paying for its AI powered software platform. See our latest analysis for Blackbaud. At a share price of US$45.36, Blackbaud has seen its short term momentum fade, with a 7 day share price return of 9.91% and a 90 day share price return of 27.23%, contributing to a 1 year...

Zscaler recently reported second-quarter fiscal 2026 results, with sales rising to US$815.75 million while net loss widened to US$34.31 million and the company raised its full-year revenue and annual recurring revenue guidance. Despite the larger loss, the guidance increase suggests management sees continued demand momentum for its cloud-based zero trust security platform. Next, we will examine how Zscaler’s upgraded full-year revenue outlook affects its investment narrative built around...

Why this leadership shake-up matters for L3Harris Technologies (LHX) L3Harris Technologies (LHX) has reorganized its top ranks as geopolitical conflicts keep defense spending in focus, appointing Kenneth Sharp as Chief Financial Officer while assigning Kenneth Bedingfield to concentrate on the Missile Solutions business. This move comes as the company prepares a potential initial public offering of its Missile Solutions unit and looks to respond to urgent missile demand, supported by a US$1b...

PPL (PPL) is planning more than 55 large grid projects and a wider smart grid rollout in 2026, supported by an infrastructure plan of over US$8 billion through 2029 and a pending distribution base rate increase. See our latest analysis for PPL. Recent trading has been a bit choppy for PPL, with a 1 day share price return of 1.23% decline and a 7 day share price return of 1.07% decline. However, the 30 day and 90 day share price returns of 5.35% and 13.77%, together with a 1 year total...

Amneal Pharmaceuticals recently reported fourth-quarter and full-year 2025 results showing sales rising to US$814.32 million for the quarter and US$3.02 billion for the year, alongside a move from a full-year net loss to net income of US$72.06 million and positive earnings per share. On the same day, the company issued 2026 net revenue guidance of US$3.05 billion to US$3.15 billion, signaling management’s confidence following its return to profitability and ahead of its March 2026...

ManpowerGroup (MAN) is back in focus after its latest Employment Outlook Survey showed a 31% global Net Employment Outlook for Q2 2026, alongside a new AI-powered interviewing partnership with Hubert. See our latest analysis for ManpowerGroup. Despite the upbeat hiring survey and AI interviewing partnership, ManpowerGroup’s share price has been under pressure, with a 30 day share price return of a 24.29% decline and a 1 year total shareholder return of a 51.66% loss. This points to fading...

In recent days, Intercontinental Exchange announced plans to launch four New York Shipping Exchange-indexed container freight futures in April 2026 and revealed a minority investment and board seat in blockchain and trading firm OKX, alongside a broad collaboration on crypto market infrastructure and regulated digital asset products. These moves deepen ICE’s reach into both physical trade hedging and digital assets, extending its data and trading footprint across global shipping routes and...

What triggered the latest focus on Byrna Technologies stock? Byrna Technologies (BYRN) is back in focus after appointing Conn Davis as CEO and issuing preliminary Q1 FY2026 revenue guidance of about US$29.0 million, along with comments on omnichannel expansion and shipment timing. See our latest analysis for Byrna Technologies. The CEO transition on March 3 and the preliminary Q1 FY2026 revenue guidance have arrived against a weak backdrop for the stock, with a 30 day share price return of...

Why Tecnoglass Stock Is Back in Focus After Fresh Earnings and Buybacks Tecnoglass (TGLS) just paired its latest quarterly and full year 2025 results with fresh 2026 revenue guidance and an update on a completed share repurchase program, giving investors several new data points to assess. See our latest analysis for Tecnoglass. Despite fresh earnings, new 2026 revenue guidance and a completed buyback program, Tecnoglass’ share price has given up ground in recent months, with a 30 day share...

Carrier Global (CARR) is back in focus after introducing the AquaEdge 30CF air cooled centrifugal chiller, a data center focused system aimed at maintaining cooling performance and uptime under demanding real world conditions. See our latest analysis for Carrier Global. At a share price of US$58.43, Carrier Global has seen pressure in the near term, with a 7 day share price return of a 4.48% decline and a 30 day share price return of an 8.59% decline. A 90 day share price return of 9.42% and...

RingCentral has launched RingCentral AIR Pro, an AI powered, voice first omnichannel agent platform. The platform offers a no code environment for building and deploying digital agents across channels. AIR Pro debuts with healthcare focused capabilities, including support for integrations with major electronic health record systems. RingCentral, traded as NYSE:RNG, is introducing AIR Pro at a time when its shares trade around $40.69. The stock has seen strong recent momentum, with returns...

In March 2026, ASP Isotopes’ subsidiary Quantum Leap Energy LLC signed a non-binding MOU with a large publicly traded U.S. energy company to explore developing U.S.-based facilities for producing HALEU, LEU+ and providing uranium conversion and deconversion services. This potential collaboration directly addresses U.S. efforts to build a more secure domestic nuclear fuel supply chain ahead of the planned 2028 ban on Russian uranium imports. We will now examine how this planned U.S. advanced...

Crescent Energy (CRGY) is back in focus after completing a US$600 million convertible notes offering and filing a smaller ESOP related shelf registration, a financing combination that has drawn fresh analyst attention. See our latest analysis for Crescent Energy. The financing news has arrived in the context of strong recent momentum, with a 30 day share price return of 16.90% and a year to date share price return of 39.01%. The 1 year total shareholder return of 19.60% and 3 year total...

If you are wondering whether Union Pacific's share price still offers value after recent moves, this breakdown will help you weigh what you are paying against what you are getting. The stock closed at US$250.21, with a 7.9% year-to-date return and a 37.4% return over 3 years. The last 7 days showed a 5.9% decline and the last 30 days a 1.0% decline, which may have shifted how some investors think about its upside and risk. Recent headlines around Union Pacific have focused on its role as a...

In early 2026, Wendy’s said it would close between 300 and 600 underperforming U.S. restaurants in the first half of the year while advancing its Project Fresh turnaround plan. At the same time, the company moved to accelerate international growth by finalizing franchise agreements for more than 60 new restaurants in Mexico, underscoring a shift in where it sees the strongest long-term potential. Next, we’ll examine how closing weaker U.S. locations while accelerating Mexican expansion could...

Tenaya Therapeutics recently announced a research collaboration with Alnylam Pharmaceuticals to validate up to 15 gene targets for cardiovascular disease over two years, with Tenaya receiving up to US$10,000,000 upfront plus cost reimbursement and potential milestone payments of up to US$1.13 billion if all targets lead to approved therapies. This agreement could broaden Alnylam’s RNAi pipeline beyond its core transthyretin focus by adding genetically validated cardiovascular targets that...

Welltower Inc. recently closed an amended US$6.25 billion senior unsecured revolving credit facility, extending maturities to 2029–2030, modestly reducing pricing, and using cash on hand to repay its prior US$1.00 billion and C$250.00 million term loans while increasing total available credit facilities to about US$7.50 billion. By improving its credit outlook, lowering its borrowing spread to 67.5 basis points over SOFR, and adding the option to further upsize the facility, Welltower has...

If you are wondering whether Equinix is priced attractively or already reflects a lot of optimism, you are in the right place to unpack what the current share price might be implying. At a recent close of US$956.07, Equinix has posted a 12.7% return over the last 30 days, 25.1% year to date, and 17.0% over the past year, with a 47.3% return over 3 years and 57.0% over 5 years, despite a 1.6% decline in the last week. Recent attention on Equinix has been driven more by its role in digital...

Yalla Group (YALA) has rounded out FY 2025 with fourth quarter revenue of about US$83.9 million and basic EPS of US$0.23, against a trailing twelve month EPS of US$0.96 that sits alongside earnings growth of 10.4% year on year. Over the past six quarters in the dataset, revenue has moved within a tight band between roughly US$83.9 million and US$90.8 million per quarter, while quarterly EPS has ranged from about US$0.20 to US$0.27, feeding into a trailing net profit margin of 43.8% that is...

If you are wondering whether Applied Materials' current share price still offers value after a big run, this article walks through how its valuation stacks up using several common methods. The stock recently closed at US$345.88, with returns of 7.2% over the past 30 days, 28.6% year to date, and 137.4% over the last year, which has reshaped how many investors think about its risk and return profile. Recent news around the broader semiconductor and AI supply chain has kept Applied Materials...

General Mills (GIS) stock is back in focus after Q2 2026 results highlighted about 25% growth in new product innovation, market share gains in 8 of its top 10 categories, and management’s more confident second half outlook. See our latest analysis for General Mills. Despite the Q2 2026 update and recent product news around K 12 reformulations and entertainment tie ins, momentum in the shares has been weak. A 30 day share price return of 11.68% and a 1 year total shareholder return of 28.77%...

GE HealthCare Technologies (GEHC) just secured FDA 510(k) clearance for View, its cloud-native diagnostic viewer within the Genesis Radiology Workspace. This regulatory milestone could influence how investors think about the stock. See our latest analysis for GE HealthCare Technologies. Despite the FDA clearance for View and a steady stream of product news and conference appearances in early March, GE HealthCare’s share price has been under pressure, with a 30 day share price return of 9.82%...

Why CG Oncology Is On Investors’ Radar CG Oncology (CGON) has been drawing attention after a strong run in recent months, with the stock showing double digit gains over the past month and past 3 months. See our latest analysis for CG Oncology. With the share price at $62.80, CG Oncology has seen a 24.7% 1 month share price return and a 50.3% year to date share price return, while the 1 year total shareholder return stands at 138.8%, pointing to strong momentum over both shorter and longer...

If you are wondering whether Mastercard is priced fairly or if the recent weakness has opened a window of opportunity, this breakdown will help you see what the current share price actually implies. After a strong multi year run, with a 48.5% return over 3 years and 38.5% over 5 years, the stock is currently below its recent levels, with a 1.8% decline over 7 days, 6.2% over 30 days and 8.6% year to date, leaving it 1.5% lower over the past year. Recent attention on Mastercard has focused on...